Corcept Therapeutics Incorporated Profile Avatar - Palmy Investing

Corcept Therapeutics Incorporated

Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral m…

Biotechnology
US, Menlo Park [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Corcept Therapeutics Incorporated has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Corcept Therapeutics Incorporated can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Corcept Therapeutics Incorporated.

End of CORT's Analysis
CIK: 1088856 CUSIP: 218352102 ISIN: US2183521028 LEI: - UEI: -
Secondary Listings
CORT has no secondary listings inside our databases.